Stocks-ADVM-Adverum Biotechnologies Inc

ADVM Adverum Biotechnologies Inc

0.6780 0.0081 (1.21%)
Invest
Invest
-1.97% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
67.62M
Day’s Range
0.6300
-
0.6550
52W Range
0.6100
-
1.98
Volume (3M)
496.25K
Price-Earnings Ratio
-
Revenue
-
Top Discussions
MarketUpdates
$ADVM (Adverum Biotechnologies Inc) Q4 2022 earnings report is expected to be released
2
MAR
REPORTS
Adverum Biotechnologies Inc Q4 2022 earnings report is expected to be released after market open
Notify me
ADVM
ADVM
Adverum Biotechnologies Inc
0.6780
0.0081
(1.21%)
Trade
MarketUpdates
$ADVM (Adverum Biotechnologies Inc) Q4 2022 earnings report is expected to be released
2
MAR
REPORTS
Adverum Biotechnologies Inc Q4 2022 earnings report is expected to be released after market open
Notify me
ADVM
ADVM
Adverum Biotechnologies Inc
0.6780
0.0081
(1.21%)
Trade
wasi7499
These tripe stocks hurt me too much when i see them so cheap. Seeing no progress from 2 years. $ADMP (Adamis Pharmaceuticals Corp) $ATNX (Athenex Inc) $ADVM (Adverum Biotechnologies Inc)
wasi7499
I don't think that we will ever see a bull run again in stock market in nearest future. At least 3-4 years we will have to wait $ATNX (Athenex Inc) $DOYU (Douyu ) $TME (Tencent Music Entertainment Group) $SKLZ (Skillz Inc) $ADVM (Adverum Biotechnologies Inc)
MarketUpdates
Edited
$ADVM (Adverum Biotechnologies Inc) Q3 2022 earnings report is expected to be released
10
NOV
REPORTS
Adverum Biotechnologies Inc Q3 2022 earnings report released after market open
ADVM
ADVM
Adverum Biotechnologies Inc
0.6780
0.0081
(1.21%)
Trade
ADVM
Adverum Biotechnologies Inc
0.6470
0.0081 (1.21%)
Trade

About Adverum Biotechnologies Inc

Operating within the US, Adverum Biotechnologies is a healthcare company founded in 2006 and headquartered in Emeryville, California. The firm is a clinical-stage gene therapy company engaged in developing gene therapy product candidates to treat ocular and rare diseases. Trading on the NASDAQ CM, the firm uses the ticker ACVM. Consider adding ACVM stock to diversify your eToro portfolio.
188
Employees
Redwood City, California, US
HQ
2006
Founded
Laurent Fischer, MD
CEO
Show More

Upcoming Earnings

2
MAR
REPORTS
Adverum Biotechnologies Inc Q4 2022 earnings report is expected to be released after market open

People Also Bought